GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Society of Pharmaceutical Tecnocrats ; 2023
    In:  International Journal of Drug Regulatory Affairs Vol. 11, No. 3 ( 2023-09-17), p. 62-67
    In: International Journal of Drug Regulatory Affairs, Society of Pharmaceutical Tecnocrats, Vol. 11, No. 3 ( 2023-09-17), p. 62-67
    Abstract: The main purpose of this article is to research the requirement of the veterinary drug dossier submission in the three countries is US, EU, and Canada and the procedure of all the three countries are different for the submission of the veterinary drug dossier and their rules and regulation are different but all the three countries follow the VICH guidelines in these articles all the information available like necessary documents timeline approval procedure are different for US, EU, and Canada.
    Type of Medium: Online Resource
    ISSN: 2321-6794 , 2321-7162
    Language: Unknown
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date: 2023
    detail.hit.zdb_id: 2738279-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Society of Pharmaceutical Tecnocrats ; 2023
    In:  International Journal of Drug Regulatory Affairs Vol. 11, No. 1 ( 2023-03-17), p. 43-46
    In: International Journal of Drug Regulatory Affairs, Society of Pharmaceutical Tecnocrats, Vol. 11, No. 1 ( 2023-03-17), p. 43-46
    Abstract: Food & Drug Control Administration (FDCA), can be credited with an iron hand and will of the regulator combined with the strict vigil and a friendly hand holding for all of its stake holders i.e., manufacturers of drugs, wholesalers, retailers, stockiest, C & F agents etc. The enforcement mission targets to fulfill the objective of making available the safe and effective medicines by ensuring that the menace of manufacture of spurious /substandard drugs is eradicated. For the enforcement activities it is vital to have immediate and accurate access to information as well as there is a need to communicate effectively and quickly with the stake holders. Prior to the initiative of implementation of software, SMS alerts etc. the enforcement task was dependent on manual means of actions and communications. Gujarat FDCA implemented web-based software - Xtended Licensing & Laboratory Node (XLN), http://xlnfda.guj.nic.in/login.aspx, with data stored in the central server. The aim behind e-governance was to create a system to bring about transparency, traceability, simplicity, effectiveness, harmonization, speed, accuracy and accountability in various G2G, G2C and G2B functions of the department and to attain & maintain FDCA’s leadership in drug regulations in India.
    Type of Medium: Online Resource
    ISSN: 2321-6794 , 2321-7162
    Language: Unknown
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date: 2023
    detail.hit.zdb_id: 2738279-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Society of Pharmaceutical Tecnocrats ; 2023
    In:  International Journal of Drug Regulatory Affairs Vol. 11, No. 3 ( 2023-09-19), p. 53-61
    In: International Journal of Drug Regulatory Affairs, Society of Pharmaceutical Tecnocrats, Vol. 11, No. 3 ( 2023-09-19), p. 53-61
    Abstract: Nutraceuticals are products that are rich in nutrients and provide health benefits, because of many factors like lifestyle changes and change in the dietary habits of people now a day, these products are widely used. Among all the other categories of Nutraceuticals Dietary supplement comprises huge part of Nutraceuticals. They are distinguishable from conventional food or drugs. They are intended to use to supplement the normal diet. The terms, nomenclature and definitions of the dietary supplements vary throughout the world. Different countries have their own regulation and legislative requirements. In regulated countries streamlined regulations are there, while well-structured and streamlined regulations for Nutraceuticals are lacking in other countries. In developing and emerging nations the regulation of dietary supplements are constantly evolving. It is necessary that the product complies all the regulatory requirements before they are placed on the market. The proposed study is based on the regulation and legislative requirements of dietary supplements in Brazil, Russia, India and South Africa.
    Type of Medium: Online Resource
    ISSN: 2321-6794 , 2321-7162
    Language: Unknown
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date: 2023
    detail.hit.zdb_id: 2738279-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Society of Pharmaceutical Tecnocrats ; 2023
    In:  International Journal of Drug Regulatory Affairs Vol. 11, No. 1 ( 2023-03-17), p. 31-42
    In: International Journal of Drug Regulatory Affairs, Society of Pharmaceutical Tecnocrats, Vol. 11, No. 1 ( 2023-03-17), p. 31-42
    Abstract: Most clinical studies were carried out in the United States, Europe, and Japan up until 1995. In 1995, the first assessment of research in India was completed. A 2004 article suggested that India lacked the ideal research environment that the majority of clinical researcher’s demand. Clinical trials carried out in India significantly increased in 2009. A public interest litigation (PIL) was filed in 2012 accusing government, non-governmental, and independent investigators of conducting clinical studies improperly. The Drugs and Cosmetics Rules of 1945's Schedule Y, which govern clinical trials, were previously followed (D & C Rules). The Drugs and Cosmetics Act, 1940 (D & C Act) is the legal framework for the New Drugs and Clinical Trials Rules, 2019, or "NDCT Rules," which put an end to the protracted process of codifying the regulations that apply to clinical trials. Clinical trials, studies on bioequivalence and bioavailability, ethics committees, and investigational novel medications for human use will all be subject to the new regulations. As of 13-01-2o22, the Union Health Ministry has published a final notification revising the New Drugs and Clinical Trials (ND & CT) Rules, 2019 to include cell derived products as well as stem cell derived products under the definition of new medication.
    Type of Medium: Online Resource
    ISSN: 2321-6794 , 2321-7162
    Language: Unknown
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date: 2023
    detail.hit.zdb_id: 2738279-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Society of Pharmaceutical Tecnocrats ; 2023
    In:  International Journal of Drug Regulatory Affairs Vol. 11, No. 3 ( 2023-09-17), p. 43-52
    In: International Journal of Drug Regulatory Affairs, Society of Pharmaceutical Tecnocrats, Vol. 11, No. 3 ( 2023-09-17), p. 43-52
    Abstract: Since the ancient period, people have used herbal treatments for a wide variety of medical issues. In developing countries, most people utilize herbal remedies to cure a variety of diseases. India, the nation that produces the most medicinal plants, is referred to as the botanical garden of the world. Indian drug regulators are focused on quality in order to uphold the standards for herbal remedies, but manufacturers are struggling to satisfy the higher standards. There are difficulties with standardization, finished formulations, and industry-wide evidence-based practices for AYUSH medicines in India. Phytopharmaceuticals, a modern subclass of medications, contain an enriched fraction with at least four distinct chemical markers with one biomarker. The Central Drugs Standards Control Organization (CDSCO) oversees Phytopharmaceuticals. The Ministry of Health and Family Welfare has released a Gazette Notification GSR 918(E)-Schedule Y, Appendix I(B) regarding Phytopharmaceuticals. This new rule is anticipated to encourage new medication discoveries and evolution using botanicals in a scientific manner and would aid in the modern medical profession's acceptance of Phytopharmaceuticals as a significant alternative to allopathic modern medicine. Phytopharmaceuticals are a well-balanced approach that believes in everything but places emphasis on the revalidation of the plant material's specification, in contrast to conventional pharmaceuticals that suspect everything and AYUSH medicines that trust everything. The purpose of this article is to give specific detail and compiled knowledge about Phytopharmaceutical medicines, regulatory requirements, and regulatory processes.
    Type of Medium: Online Resource
    ISSN: 2321-6794 , 2321-7162
    Language: Unknown
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date: 2023
    detail.hit.zdb_id: 2738279-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Naksh Solutions ; 2023
    In:  International Journal of Advanced Research in Science, Communication and Technology
    In: International Journal of Advanced Research in Science, Communication and Technology, Naksh Solutions
    Abstract: The field of regulatory affairs (RA) serves as a link between the global pharmaceutical sector and regulators. It was created in response to governments’ desire to safeguard the public’s health by regulating the efficacy and safety of pharmaceuticals, veterinary drugs, medical equipment, pesticides, agricultural chemicals, cosmetics, and other goods. Companies that are in charge of the development, manufacture, testing, and sale of these products aim to guarantee that they deliver safe and efficient goods for the welfare of the general public. Different registration criteria for pharmaceutical products are covered by pharmaceutical drug regulatory affairs. As a result of the demand for superior quality medicine that includes safety and efficacy in the areas of not only pharmacy but also veterinary medicine, medical devices, insecticides, pesticides, agrochemicals, cosmetic, and supplementary medicine, a new profession called pharmacy was created. Additionally, it created a connection between the pharmaceutical corporation and the regulating bodies. Maintaining the appropriateness and accuracy of the product information is another duty assigned to it. And its primary responsibility is to serve as a point of contact for regulatory agencies, providing expertise and regulatory intelligence in translating regulatory requirements into realistic, workable plans, and advising the company on regulatory aspects and the regulatory environment that would affect their proposed projects..
    Type of Medium: Online Resource
    ISSN: 2581-9429
    Language: English
    Publisher: Naksh Solutions
    Publication Date: 2023
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Society of Pharmaceutical Tecnocrats ; 2023
    In:  International Journal of Drug Regulatory Affairs Vol. 11, No. 1 ( 2023-03-20), p. 15-23
    In: International Journal of Drug Regulatory Affairs, Society of Pharmaceutical Tecnocrats, Vol. 11, No. 1 ( 2023-03-20), p. 15-23
    Abstract: A study relating to the regulation for nasal products has been conducted for the current review. The analysis emphasized the significance of classifying nasal products. Nasal products are challenging to manufacture in India due to regulatory and logistical issues. In addition to the production guidelines established by the USFDA and EU, the study analyses the prospects for nasal products in the future. Some common policies held by the 2 major international agencies have been shown in this review. The current evaluation focuses on how nasal product production should be done in conjunction with other product production and will examine the fundamental recommendations made by the USFDA and EU, as well as whether or not there is a specific category of recommendations for nasal products. Conclusions The article demonstrates the USFDA and EU guidelines, and it was found that there were not major differences between the guidelines of the two. Instead, there are only minor differences between the infrastructures of the two agencies related to nasal products.
    Type of Medium: Online Resource
    ISSN: 2321-6794 , 2321-7162
    Language: Unknown
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date: 2023
    detail.hit.zdb_id: 2738279-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Society of Pharmaceutical Tecnocrats ; 2023
    In:  International Journal of Drug Regulatory Affairs Vol. 11, No. 1 ( 2023-03-20), p. 61-70
    In: International Journal of Drug Regulatory Affairs, Society of Pharmaceutical Tecnocrats, Vol. 11, No. 1 ( 2023-03-20), p. 61-70
    Abstract: Regulatory affairs play a significant role in the pharmaceutical industry, it is “the process of gathering, reviewing, and monitoring the existing regulatory environment and creating regulatory plans and gaining a competitive edge for securing regulatory approvals required more than just acquiring facts”. A medical device is a treatment instrument that "does not work on or in the human body in a way that is primarily intended by pharmacological, immunological, or metabolic mechanisms”. In other words, a medical device is essentially any medical product, not a medicine or biological product. By the Drugs and Cosmetics Act, Central Drugs Standard Control Organization (CDSCO) oversees approving drugs, conducting clinical trials, setting standards for drugs, monitoring the quality of drugs imported into the nation, and coordinating the efforts of state drug control organizations by offering professional advice to ensure uniformity in the application of the Drugs and Cosmetics Act. The US Food and Drug Administration (FDA), a single agency, oversees the regulation of a trillion dollars’ worth of goods, or about 25 cents of every dollar spent, including 80 percent of the food supply in the US, all medical devices, and prescription drugs, animal products, cosmetics, and even the production of tobacco products. The FDA's Center for Devices and Radiological Health regulates companies that produce, repackage, re-label, and/or import medical devices sold in the United States (CDRH). Also, CDRH is in charge of overseeing the regulation of lasers, x-ray machines, ultrasound equipment, microwave ovens, and color televisions, among other electronic gadgets that generate radiation for both medical and non-medical purposes. The IMDR, which was published in January 2017 and became effective in January 2018, was produced by the Medical Devices and Diagnostics Division of CDSCO and is a set of structured regulations for medical devices. In February 2020, the "Medical Devices (Amendment) Regulations, 2020" were established, and they became effective in April 2020. The 2020 amendment now includes a new clause called "registration of specific medical equipment."
    Type of Medium: Online Resource
    ISSN: 2321-6794 , 2321-7162
    Language: Unknown
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date: 2023
    detail.hit.zdb_id: 2738279-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    Society of Pharmaceutical Tecnocrats ; 2023
    In:  International Journal of Drug Regulatory Affairs Vol. 11, No. 1 ( 2023-03-20), p. 47-53
    In: International Journal of Drug Regulatory Affairs, Society of Pharmaceutical Tecnocrats, Vol. 11, No. 1 ( 2023-03-20), p. 47-53
    Abstract: Introduction: During the COVID-19 pandemic, surgical masks have become a crucial protective measure to prevent the spread of the virus. While they are regulated as medical devices to ensure their effectiveness, the high demand for masks has led to an increase in counterfeit products that pose a threat to public health. Materials and methods: In Chandigarh, India, a cross-sectional study was conducted with 350 individuals aged 15 and above who had access to social networks. An online questionnaire consisting of 20 questions on knowledge, practice, and demographics was used to collect data through convenience sampling with a chain-sampling method. Descriptive statistics and correlation and linear regression analysis were performed using SPSS version 29.0 to find a statistically significant relationship between knowledge, practice, and demographic variables. Result: Of 350 participants in the survey 26.0% were aged 15-29, 32.6% were aged 30-39, 13.4% were aged 40-49, and 28.0% were aged 50-80. In terms of gender, 49.1% were male and 50.9% were female. The majority had a master's degree (45.7%) and were employed in the private sector (49.4%). Education had a significant impact on knowledge (t-value of 11.375, significance level 〈 .001), but job type did not (t-value of -1.740, significance level .083). Participants' knowledge and practice had a strong positive correlation (Pearson Correlation coefficient of 1.000, significance level 〈 .001). The constant (intercept) was significant in predicting practice, while age, gender, and job were not (significance levels 〉 .05). Conclusion: The study found that the community had satisfactory awareness and practice of using certified and licensed surgical masks. However, there is a need for reinforced education on the topic. The researchers recommend mass media campaigns and strict government regulation to ensure the use of certified masks and prevent the use of counterfeit ones. Continuous education is also necessary to help the public understand the importance of using certified and licensed masks for maximum protection.
    Type of Medium: Online Resource
    ISSN: 2321-6794 , 2321-7162
    Language: Unknown
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date: 2023
    detail.hit.zdb_id: 2738279-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    Society of Pharmaceutical Tecnocrats ; 2023
    In:  International Journal of Drug Regulatory Affairs Vol. 11, No. 3 ( 2023-09-18), p. 11-21
    In: International Journal of Drug Regulatory Affairs, Society of Pharmaceutical Tecnocrats, Vol. 11, No. 3 ( 2023-09-18), p. 11-21
    Abstract: There is a significant demand for improved healthcare and advanced pharmaceuticals in Brazil, presenting lucrative opportunities for foreign investors. However, engaging in business activities in Brazil can be challenging due to various factors. The process of registering pharmaceutical products in the country is time-consuming. Moreover, the highly regulated, complex, and fragmented Brazilian healthcare system, which is prone to corruption, can pose significant difficulties for small and medium-sized enterprises lacking the necessary financial resources and market knowledge. To comply with regulations, companies must provide detailed information about their drug products, including specifications, leaflets/labels, precautions, and other crucial details, all of which must be submitted in Portuguese in a comprehensive dossier. It typically takes close to a year to complete the medical registration process. In Latin America, specifically Brazil, Argentina, and Chile, there is a push to promote the registration of generic products by reducing the associated costs. Despite the obstacles and issues faced, Brazil's population of nearly 200 million people, its strategic position within Latin America, and its growing economy collectively present an appealing and promising market for various pharmaceutical sectors, offering potential for profitability.
    Type of Medium: Online Resource
    ISSN: 2321-6794 , 2321-7162
    Language: Unknown
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date: 2023
    detail.hit.zdb_id: 2738279-5
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...